Lowering Drug Costs for American Families Act expands the drug price negotiation program, applies prescription drug inflation rebates to commercial.
The Lowering Drug Costs for American Families Act expands the drug price negotiation program under the Social Security Act to include more drugs. It requires consideration of the average international market price for drugs during negotiations. The act also applies prescription drug inflation rebates to drugs furnished in the commercial market. Additionally, it establishes out-of-pocket limits on expenditures for prescription drugs under private health insurance, setting specific cost-sharing limits for insulin products.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.